TTrialPathMatch Me to Trials
← Back to trials
RecruitingHeart Failure With Reduced Ejection Fraction

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

Eligible age

18+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

RECOVER HF is a clinical study designed to evaluate the safety and efficacy of Synchronized Diaphragmatic Stimulation delivered using the VisONE System in the treatment of patients with heart failure.

Sponsor: VisCardia Inc.

You may qualify if…

  • ✓ NYHA classes II/III on optimal Guideline Directed Medical Therapy (GDMT)
  • ✓ QRS duration ≤ 130 ms
  • ✓ EF≤ 40%

You may not qualify if…

  • ✕ Baseline 6 minute walk test \> 500 meters or \< 200 meters
  • ✕ NT-proBNP\< 250 if on loop diuretics, or NT-proBNP \< 500 if not on loop diuretics
  • ✕ Supine resting heart rate \> 140 bpm
  • ✕ Systolic blood pressure \< 80 mmHg or \> 170 mmHg
  • ✕ Serum creatinine \> 2.5 mg/dL
  • ✕ Serum hepatic function 3x ULN
  • ✕ Any of the following within the previous 3 months: unstable angina, AMI, CABG, PTCA, CVA/TIA, persistent AF (\> 24 hours), symptomatic NSVT or DCCV
  • ✕ Any inotropic drug treatment within the previous 3 months

Where it's recruiting

Oklahoma

Tulsa

Pennsylvania

Philadelphia

Source: ClinicalTrials.gov · NCT06552637 · last updated 2026-07-30

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure · TrialPath